31results about How to "Practical therapeutic activity" patented technology

The invention relates to a cytisine derivative maleate or its pharmaceutically acceptable solvate and an application of the cytisine derivative maleate or its pharmaceutically acceptable solvate in preparation of medicines for treating tumors.

The invention relates to applications of fumarate of dehydrocheilanthifoline and derivatives thereof or pharmacology-acceptable solvate of the fumarate of dehydrocheilanthifoline and derivatives thereof on preparation of drugs for curing hepatitis B virus infection.

The invention relates to fumarates or pharmaceutically acceptable solvates of buxus microphylla base and derivatives, and an application for the same in preparation for a medicine treating cancers.

The invention relates to N-(4-((4-(3-(3-tert-butyl-1-p-methylphenyl-1H-pyrazole-5-yl) ureido) naphthalene-1-base oxygen) methyl) pyridine-2-yl)-2-methoxy acetamide and fumarate of a derivative thereof or a solvate thereof acceptable in pharmacology and an application for preparing a medicine for treating and / or relieving and / or preventing influenza.

The invention relates to fumarates of conimine derivatives or pharmaceutically acceptable solvates of the fumarates, and their use in preparation of an acetylcholinesterase inhibition drug.

The invention discloses methoxy dihydronitidine as well as fumarate of derivate or thereof pharmaceutically acceptable solvate thereof and application thereof in preparing a medicament for treating hepatitis B.

The invention relates to fumarate or pharmacological acceptable solvates of dihydrosanguinarine and derivatives of the dihydrosanguinarine as well as an application of the fumarate or pharmacological acceptable solvates to the preparation of drugs for treating hepatitis B.

The invention relates to cyclopropane-carboxylic acid {3-[6-(3-(trifluoromethyl)-phenylamino)-pyrimidine-4-yl-amino]-phenyl}-amide and a derivative fumarate or a pharmaceutically acceptable solvate thereof, and an application thereof in preparation of medicines for treating cancers.

The invention relates to 6-{difluoro-[6-(1-methyl-1H-pyrazole-4-yl)-[1,2,4] triazole [4,3-b] pyridazine-3-yl] methyl}-quinoline and a derivative fumarate or a pharmaceutically acceptable solvate thereof, and an application thereof in preparation of medicines for treating cancers.

The invention relates to fumarate or pharmaceutically acceptable solvate of oxodehydrocaaverine (7-oxodehydrocavverine) and a derivative thereof, and application of oxodehydrocaaverine in preparation of a methicillin-resistant staphylococcus aureus medicine.

The invention relates to fumarates of delta 11,12-antofine and delta 11,12-antofine derivatives or pharmaceutically acceptable solvates thereof, and an application of the fumarates or the solvates in preparing drugs for treating cancers.

The invention relates to corydine malate or a pharmaceutically acceptable solvate and an application thereof in preparation of medicaments for preventing and / or treating cervical cancer. The formula is as shown in the specification.

The invention relates to sophocarpine fumarate or its pharmaceutically acceptable solvates, and an application of the sophocarpine fumarate or its pharmaceutically acceptable solvates in the preparation of medicines for treating mycoplasma, chlamydia and fungal infection.

The invention relates to oxysophocarpine fumarate or its pharmaceutically acceptable solvates, and an application of the oxysophocarpine fumarate or its pharmaceutically acceptable solvates in the preparation of medicines for treating mycoplasma, chlamydia and fungal infection.

The invention relates to isocorydine malate or a pharmaceutically acceptable solvate thereof and an application of the compounds in preparation of medicines for preventing and / or treating cervical cancer.

The invention relates to (-)sukhodianine, a fumarate of a (-)sukhodianine derivative, or a pharmacologically acceptable solvate of the fumarate, and applications of the pharmacologically acceptable solvate in preparation of drugs used for controlling methicillin-resistant staphylococcus aureus.

The invention relates to fumarate or pharmaceutically acceptable solvates of a conessine derivative and application of fumarate or the pharmaceutically acceptable solvates to prepare acetylcholinesterase inhibitor medicaments.

The invention relates to apocavidine and fumarate or pharmaceutically acceptable solvate of a derivative of apocavidine, and an application of apocavidine and fumarate or pharmaceutically acceptable solvate in preparing a methicillin-resistant staphylococcus aureus medicine.

The invention relates to dicranostigma leptopodum berberrubine, a dicranostigma leptopodum berberrubine fumarate derivative, pharmaceutically acceptable solvates of the fumarate derivative, and applications of the solvates and the fumarate derivative for preparation of medicines treating cancer.

The invention relates to a tetrahydropalmatine derivative maleate or its pharmaceutically acceptable solvate and an application of the tetrahydropalmatine derivative maleate or its pharmaceutically acceptable solvate in preparation of medicines for treating tumors.

The invention relates to fumarate of 3-(4-acetyl piperazine-1-yl)-5-(3-nitryl benzyl amino)-7-trifluoromethyl-quinoline and a derivative or a pharmaceutically acceptable solvates of fumarate and an application of fumarate in preparation of a medicine for treating cancer.

The invention relates to fumarates of nuciferine and nuciferine derivatives or pharmaceutically acceptable solvates thereof, and an application of the fumarates or the solvates in preparation of acetylcholinesterase inhibitor drugs.

The present invention relates to fumarates of 14-hydroxyantofine and 14-hydroxyantofine derivatives or pharmaceutically acceptable solvates thereof, and an application of the fumarates or the solvates in preparation of drugs for treating cancer.

The invention relates to a fumaric acid salt of picrasma quassioides alkaloid and a derivative and a pharmaceutically acceptable solvate, and an application of fumaric acid salt and the solvate in preparation of medicine for treating cancer.

The invention relates to applications of fumarates of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholine-4-yl-methyl-phenyl)-isoxazole-3-ethylformamide and derivatives thereof, or pharmaceutically acceptable solvates in the preparation of medicines for treating cancers.

The invention relates to radix aristolochiae lactam malate or a pharmaceutically acceptable solvate thereof, and an application thereof in preparation of a medicine preventing and / or treating neurodegenerative diseases.

The invention relates to crinum asiaticum novacine and fumarate of a derivative or a pharmaceutically acceptable solvate and an application of poison bulb novacine in preparation of medicines for treating cancer.